Trust in US physicians and hospitals dropped significantly during COVID-19, affecting vaccination rates across all demographics. Restoring trust is crucial for future public health efforts.
Filgotinib maleate by Alfasigma for Giant Lymph Node Hyperplasia (Castleman’s Disease): Likelihood of Approval
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes